How should I manage a patient on bupropion who is experiencing low libido (and irritability)?

Management of Low Libido in a Patient on Bupropion

Continue bupropion, as it is the antidepressant with the lowest rate of sexual dysfunction and may actually improve libido—the low sex drive is likely not caused by the bupropion itself. 1, 2

Understanding the Clinical Context

The situation you're describing is paradoxical because bupropion is specifically known for having significantly lower rates of sexual adverse events compared to SSRIs like fluoxetine and sertraline 2. In fact, research demonstrates that 77-86% of bupropion-treated patients report no adverse sexual effects, and 77% report at least one aspect of heightened sexual functioning 3. This stands in stark contrast to SSRIs where only 27% of patients have no sexual side effects 3.

Differential Diagnosis: What's Really Causing the Low Libido?

Before attributing the sexual dysfunction to bupropion, consider these more likely culprits:

• Residual depressive symptoms: Low libido is a core symptom of depression itself. If the patient still has irritability, this suggests incomplete treatment response
• Pre-existing sexual dysfunction: Was libido assessed before starting bupropion?
• Comorbid medical conditions: Diabetes, cardiovascular disease, hormonal issues
• Other medications: Antihypertensives, other psychotropics
• Substance use: Alcohol, opiates, benzodiazepines

Management Algorithm

Step 1: Assess Treatment Response (Week 2-6)

• Irritability is a red flag 4. The FDA label specifically warns that irritability, agitation, and hostility can signal worsening depression or emerging neuropsychiatric adverse events
• Evaluate whether depressive symptoms are adequately controlled
• If depression is not in remission, the low libido may be a symptom of undertreated depression rather than a medication side effect

Step 2: If Depression is Inadequately Treated

Optimize bupropion dosing (up to 300 mg daily maximum) 4 or consider augmentation strategies rather than switching away from the one antidepressant least likely to cause sexual dysfunction

Step 3: If Depression is Well-Controlled but Libido Remains Low

This is the truly unusual scenario. Consider:

• Rule out other causes systematically (medical workup, medication review)

• Add adjunctive treatment for sexual dysfunction rather than switching:

  • PDE5 inhibitors (sildenafil, tadalafil) for erectile dysfunction 5, 6
  • Saffron (Crocus sativus) shows promise as adjunctive therapy 6

• Switch only as a last resort to:

  • Mirtazapine (though associated with weight gain and somnolence) 5, 6
  • Vortioxetine (newer agent with potentially favorable sexual profile) 6

Critical Pitfall to Avoid

Do not switch to an SSRI or SNRI thinking it will help with sexual function. This would be moving from the antidepressant with the lowest sexual dysfunction rate (14% with bupropion) to medications with significantly higher rates (30-70% with SSRIs) 2, 3. Paroxetine in particular has the highest rates of sexual dysfunction among all antidepressants 1, 2.

Addressing the Irritability

The irritability component requires immediate attention as it may represent:

• Worsening depression requiring dose optimization
• Emerging neuropsychiatric adverse event requiring close monitoring 4
• Activation syndrome (though less common with bupropion than SSRIs)

Monitor closely for escalation to agitation, hostility, or suicidal ideation, which would warrant immediate intervention 4.

Evidence Quality Note

The guideline evidence consistently shows bupropion's favorable sexual side effect profile across multiple studies 1, 2. The 2022 meta-analysis specifically examining bupropion for female sexual dysfunction found it nearly three-fold more favorable in improving sexual desire 7, and the 1997 comparative study demonstrated prosexual effects in the majority of patients 3. The most recent 2026 scoping review confirms bupropion and mirtazapine as having the most favorable sexual profiles among antidepressants 5.